Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 Years

Next Previous
Trial Profile

A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 Years

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Nov 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CVI-VZV-001 (Primary) ; GSK 137173A
  • Indications Herpes zoster
  • Focus Adverse reactions
  • Sponsors Cha Vaccine Institute

Most Recent Events

  • 23 Nov 2023 New trial record
  • 13 Oct 2023 According to a Cha Vaccine Institute media release, CHA Vaccine Research Institute had received approval for a change in trial from the Ministry of Food and Drug Safety. A third group will be added to the study with an increased vaccine dose in order to further confirm the maximum tolerance effect in the existing clinical trial design (group 1, group 2, control group).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top